Impaired cotranslational processing as a mechanism for type I antithrombin deficiency

Blood

Volumn 92, Issue 12, 1998, Pages 4671-4676

  Fitches, Alison C ^b   Appleby, Ruth ^b   Lane, David A ^b   De Stefano, Valerio ^b   Leone, Giuseppe ^b   Olds, Robin J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; COMPLEMENTARY DNA; GLYCOSYLATED PROTEIN; SECRETORY PROTEIN; SIGNAL PEPTIDE; TRYPSIN;

ADULT; ANIMAL CELL; ANTITHROMBIN DEFICIENCY; ARTICLE; CASE REPORT; CELL STRAIN COS1; CONTROLLED STUDY; DOG; ENDOPLASMIC RETICULUM; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN SECRETION; VEIN THROMBOSIS;

EID: 0032534998     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.12.4671     Document Type: Article

References (32)

1. Olds RJ, Lane DA, Mille B, Chowdhury V, Thein SL: Antithrombin: The principal inhibitor of thrombin. Semin Thromb Hemost 20:353, 1994
2. Marcum J, Rosenberg R: Anticoagulantly active heparin-like molecules from vascular tissue. Biochemistry 23:1730, 1984
3. Egeberg O: Inherited antithrombin III deficiency causing thrombophilia. Thromb Diath Haemorrh 13:516, 1965
4. Hirsh J, Piovella F, Pini M: Congenital antithrombin III deficiency. Incidence and clinical features. Am J Med 87:34S, 1989 (suppl 3B)
5. Tait RC, Walker ID, Perry DJ, Islam SI, Daly ME, McCall F, Conkie JA, Carrell RW: Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 87:106, 1994
6. van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane DA: Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost 75:417, 1996
7. Lane DA, Bayston T, Olds RJ, Fitches AC, Cooper DN, Millar DS, Jochmans K, Perry DJ, Okajima K, Thein SL, Emmerich J: Antithrombin mutation database: 2nd (1997) update. Thromb Haemost 77:197, 1997
8. Olds RJ, Lane DA, Chowdhury V, Sas G, Pabinger I, Auberger K, Thein SL: (ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations. Hum Mutat 4:31, 1994
9. Tomilo M, Wilkinson KS, Ryan P: Can a signal sequence become too hydrophobic? J Biol Chem 269:32016, 1994
10. Walter P, Johnson AE: Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane. Annu Rev Cell Biol 10:87, 1994
11. Jain RG, Rusch SL, Kendall DA: Signal peptide cleavage regions. Functional limits on length and topological implications. J Biol Chem 269:16305, 1994
12. Chowdhury V, Olds RJ, Lane DA, Conard J, Pabinger I, Ryan K, Bauer KA, Bhavnani M, Abildgaard U, Finazzi G, et al: Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening. Br J Haematol 84:656, 1993
13. De Stefano V, Leone G, De Carolis S, Ferrelli R, Di Donfrancesco A, Monete E, Bizzi B: Management of pregnancy in women with antithrombin III congenital defect: Report of four cases. Thromb Haemost 59:193, 1988
14. Olds RJ, Lane DA, Chowdhury V, De Stefano V, Leone G, Thein SL: Complete nucleotide sequence of the antithrombin gene: Evidence for homologous recombination causing thrombophilia. Biochemistry 32:4216, 1993
15. Sheffield WP, Blajchman MA: Site-directed mutagenesis of the P2 residue of human antithrombin. FEBS Lett 339:147, 1994
16. von Heijne G: Signal sequences. The limits of variation. J Mol Biol 184:99, 1985
17. van Boven HH, Olds RJ, Thein SL, Reitsma PH, Lane DA, Briet E, Vandenbroucke JP, Rosendaal FR: Hereditary antithrombin deficiency: Heterogeneity of the molecular basis and mortality in Dutch families. Blood 84:4209, 1994
18. Rittig S, Robertson GL, Siggaard C, Kovacs L, Gregersen N, Nyborg J, Pedersen EB: Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet 8:107, 1996
19. Ito M, Oiso Y, Murase T, Kondo K, Saito H, Chinzei T, Racchi M, Lively MO: Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus. J Clin Invest 91:2565, 1993
20. Racchi M, Watzke HH, High KA, Lively MO: Human coagulation factor X deficiency caused by a mutant signal peptide that blocks cleavage by signal peptidase but not targeting and translocation to the endoplasmic reticulum. J Biol Chem 268:5735, 1993
21. Daly M, Brace D, Perry DJ, Price J, Harper PL, O'Meara A, Carrell RW: Antithrombin Dublin (-3 Val→Glu): An N-terminal variant which has an aberrant signal peptidase cleavage site. FEBS Lett 273:87, 1990
22. Pomponio RJ, Reynolds TR, Cole H, Buck GA, Wolf B: Mutational hotspot in the human biotinidase gene causes profound biotinidase deficiency. Nat Genet 11:96, 1995
23. Parrott CL, Alsayed N, Rebourcet R, Santamarina-Fojo S: ApoC-IIParis2: A premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome. J Lipid Res 33:361, 1992
24. Cama A, Sierra ML, Kadowaki T, Kadowaki H, Quon MJ, Rudiger HW, Dreyer M, Taylor SI: Two mutant alleles of the insulin receptor gene in a family with a genetic form of insulin resistance: A 10 base pair deletion in exon 1 and a mutation substituting serine for asparagine-462. Hum Genet 95:174, 1995
25. Lagerstrom-Fermer M, Nilsson M, Backman B, Salido E, Shapiro L, Pettersson U, Landegren U: Amelogenin signal peptide mutation: Correlation between mutations in the amelogenin gene (AMGX) and manifestations of X-linked amelogenesis imperfecta. Genomics 26:159, 1995
26. Karaplis AC, Lim SK, Baba H, Arnold A, Kronenberg HM: Inefficient membrane targeting, translocation, and proteolytic processing by signal peptidase of a mutant preproparathyroid hormone protein. J Biol Chem 270:1629, 1995
27. Seppen J, Steenken E, Lindhout D, Bosma PJ, Elferink RP: A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett 390:294, 1996
28. Chou MM, Kendall DA: Polymeric sequences reveal a functional interrelationship between hydrophobicity and length of signal peptides. J Biol Chem 265:2873, 1990
29. Hopp TP, Woods KR: Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 78:3824, 1981
30. Kyte J, Doolittle RF: A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105, 1982
31. Briggs MS, Gierasch LM: Exploring the conformational roles of signal sequences: Synthesis and conformational analysis of lambda receptor protein wild-type and mutant signal peptides. Biochemistry 23:3111, 1984
32. Chou P, Fasman G: Prediction of protein conformation. Biochemistry 13:222, 1974